NCT05363059 Effect of Bariatric Surgery Versus Medical Therapy on Metabolic Syndrome
| NCT ID | NCT05363059 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Third Military Medical University |
| Condition | Metabolic Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2010-05-01 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2010-05-01 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bariatric surgery (BS) is known to improve the components of metabolic syndrome (MS) in obese patients. However, few studies have evaluated the impact of bariatric surgery versus medical therapy (MT) in patients with MS, especially in patients with low body mass index (BMI). This study aimed to assess the effect of bariatric surgery on MS in patients with low BMI by comparing BS (BMI\<35 kg/m2 and BMI≥35 kg/m2) with MT (BMI\<35 kg/m2). A retrospective study including patients with MS undergoing bariatric surgery and medical therapy at a single institution. We follow up the 5 years effect of bariatric surgery versus medical therapy on the remission of MS, its individual components, atherosclerotic cardiovascular disease (ASCVD) risk, and medication used.
Eligibility Criteria
1. Inclusion Criteria: * BMI\<35 kg/m\^2 * Underwent bariatric surgery or medical therapy * Patients met the diagnostic criteria for MS, defined criteria derived from the joint interim statement (JIS) 2. Exclusion Criteria: * Patients who failed to follow up * Insulin dependent diabetes * congenital dementia * brain trauma * epileps * severe hypoglycemic coma * cerebrovascular disease * ischemic * heart disease * renal dysfunction * alcohol abuse * mental illness * psychoactive substance abuse * unwillingness to provide informed consent
Frequently Asked Questions
Who can join the NCT05363059 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Metabolic Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05363059 currently recruiting?
Yes, NCT05363059 is actively recruiting participants. Visit ClinicalTrials.gov or contact Third Military Medical University to inquire about joining.
Where is the NCT05363059 trial being conducted?
This trial is being conducted at Chongqing, China.
Who is sponsoring the NCT05363059 clinical trial?
NCT05363059 is sponsored by Third Military Medical University. The trial plans to enroll 200 participants.